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Abstract 
 
This thesis discusses the background information regarding the physiological effects the 
pig encounters during weaning as well as a potential factor that can be used to assist the pig 
during this time. Specifically, the research focus is to assess the ability of the tri-peptide opioid 
agonist, Syndyphalin-33 (SD-33), to increase feed intake and body weight and modulate immune 
responses during the post-weaning period. The results of this research have demonstrated that 
SD-33 increases feed intake, transiently increases growth hormone and cortisol levels, and 
increases total white blood cell counts while selectively increasing monocyte numbers in healthy 
weaned pigs. This research also demonstrates that, although co-treatment with SD-33 during an 
immune challenge of Salmonella enterica did not result in increased feed intake, SD-33 exerted 
effects relating to increasing the circulating populations of immune cells at 48 h postinjections, 
selectively increasing monocyte numbers. Based on these results, SD-33 may have the potential 
to be used as an agent to decrease the negative effects of stress during weaning in pigs.  
However, further investigation is needed to better understand the timing of effect, and to rule out 
any immunosuppressive effects, which would be detrimental to the animal’s well-being. 
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CHAPTER ONE:  
Literature Review 
Introduction  
Commercial swine producers must raise and sell a large number of healthy and fast 
growing pigs to be economically profitable. The pig’s average daily gain, meat grade, and 
percent yield are all prerequisites for profitability. Many management practices relating to 
biosecurity and herd well-being are put into place in order for swine producers to reach such 
goals (Market Segment Specialization Program, 2001). However, the weaning process continues 
to be a major setback for producers.  
 Symptoms of stress associated with weaning are first typically seen in pigs upon arrival 
to the nursery, where pigs are faced with new social, environmental, health, and nutritional 
factors. Presentation of these changes all at once can be very taxing to the pig and often a 
physiological response ensues. Weanlings can quickly become fatigued, having a suppressed 
immune system and a loss of appetite that results in a decrease in body weight and lean muscle 
(Feuchter, 2004; USDA, 2008). Depending on how each individual pig copes, these weaning 
stress symptoms may lead to post-weaning mortality, ultimately decreasing the collective 
profitable gain. The USDA’s National Animal Health Monitoring System (USDA, 2008) 
reported that due to infection, trauma, or starvation (among other unidentified problems), there is 
2.9% mortality rate in the nursery phase. Along with mortality impacts to the industry, treating 
sick pigs due to illness or stress also increases costs, slows pig growth due to the recovery 
period, and prolongs the time before the pig goes to market. These stress-associated mortality 
rates add to a large sum annually. Under average market conditions, improving the survival by 
one piglet per litter would be worth approximately $400 million annually to the U.S. swine 
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industry (USDA-CSREES W173 report, 2006). This statistic does not include the costs of labor, 
medication, and lost weight for animals that are affected by weaning but survive. 
 This literature review will cover background information regarding the physiological 
effects the pig encounters during weaning as well as potential factors that can be used to assist 
the pig during this time. Understanding physiological pathways affected during weaning are 
necessary to design strategies to relieve negative effects of weaning-related stress. Specifically, 
this research focuses on strategies to increase feed intake and body weight and modulating 
immune responses during the post-weaning period by utilizing the tri-peptide opioid agonist 
Syndyphalin-33 (SD-33). The long-term goal of this work is to improve the well-being of the 
newly weaned pig. 
Stress and Weaning 
Management of weaning-related stressors includes monitoring environmental changes 
(such as temperature, humidity), management practices (such as castration, artificial rearing, 
early weaning), nutrition, social interactions (including aggression), and other factors that can 
adversely affect the health and well-being of newly-weaned pigs. The piglet’s biological 
response to these environmental, management, nutritional, and social stressors is multifaceted 
and complex; and it affects the operation of many organ systems. Stress can suppress 
homeostasis and anabolism causing a deficit in energy that may lead to poor growth, and in 
extreme cases, death.  
Weaning stress triggers the neuroendocrine pathway, and the endocrine axes, as well as 
autonomic responses, are stimulated simultaneously. Different types of stress (physical vs. 
psychological, acute vs. chronic) produce different physiological responses. In order to 
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understand how to help piglets overcome stress, it is important to be familiar with the stress 
pathway. The following review of stress physiology is summarized from the work of Sapolsky et 
al. (2000), Eiler (2004), Sherwood et al. (2005), Aron et al. (2007), and Gardner and Nessinson 
(2007).   
Within one minute of experiencing the stressor, the autonomic nervous system sends a 
necessary distribution of energy throughout the body to only the tissues and organs that require 
such. Specifically, stress activates the sympathetic nervous system and suppresses the 
parasympathetic nervous system, as reviewed by Sapolsky et al. (2000).  
The sympathetic nerves, located in the thoracic and lumbar region of the vertebral 
column, send and receive signals through neuronal channels. Afferent neurons carry sensations 
such as heat, cold, or pain toward the brain, and efferent neurons trigger functional changes 
peripherally by innervating effector tissue (ie, smooth muscle, cardiac muscle, and glands). 
Neurotransmitters such as norepeniphrine and acetylcholine are transmitted through neuronal 
synapses regulating the degree of response to the stress stimuli. Regulated by the mega-cellular 
neurons in the paraventricular nucleus of the hypothalamus, signals project to the chromaffin 
cells of the adrenal medulla where catecholamines, such as epinephrine, norepinephrine, and 
dopamine, are secreted directly into the bloodstream. The parasympathetic nervous system has a 
tonic inhibitory effect, decreasing functions that are not necessary to maintain fight or flight 
situations. 
These events cause physiological changes that may be noticed by swine producers. Up-
regulated respiration, heart rate, blood pressure, and renal function are effects of the sympathetic 
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response. Parasympathetic effect inhibition is often manifested as a decline or termination in 
appetite.   
Along with the nervous system response, the stress-stimulated endocrine hypothalamic-
pituitary-adrenal axis (HPA) is also initiated (as reviewed by Eiler, 2004, and Aron et al., 2007).  
Initially, the endocrine axis releases corticotropin-releasing hormone (CRH) from the 
parvocellular neurons in the paraventricular nucleus of the hypothalamus. Neurons that produce 
CRH (along with vasopressin and oxytocin) project to the median eminence, which lead to the 
anterior pituitary. Oxytocin and vasopressin normally stimulate the posterior pituitary, but their 
projections to the median eminence, together with CRH, are what regulate the release of 
adrenocorticotropic hormone (ACTH) from the corticotroph cells in the anterior pituitary. For 
ACTH to be released into the bloodstream, it must be cleaved from the prohormone pro-
opiomelanocortin (POMC) by the prohormone convertase-1 enzyme in the corticotroph cells of 
the anterior pituitary. The ACTH release acts on its receptors in the zona fasciculata cortex 
region of the adrenal gland to release glucocorticoids. Cortisol is the primary glucocorticoid in 
the pig. 
Once cortisol is synthesized and secreted from the adrenal cortex, it is transported within 
the circulation either bound to carrier proteins (corticosteroid-binding globulin [CBG] and 
albumin) or in the unbound/free state (Gardner and Nessinson, 2007). The half-life of cortisol 
within the circulation is determined to some extent by its association with these binding proteins 
in that they prevent cortisol from being excreted by the kidneys.  In particular, CBG has a high 
affinity, but low capacity for binding cortisol compared with that of albumin.  Cortisol bound to 
CBG is considered to be biologically inactive, whereas the albumin-bound and unbound cortisol 
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is biologically available to the cell. Therefore, the biological impact of cortisol concentration 
within the circulation will depend on both total cortisol levels as well as the concentration of 
CBG in the bloodstream.  
Free cortisol and CBG-bound cortisol travel through the bloodstream and bind to two 
types of receptors: mineralocorticoid and glucocorticoid receptors (Sherwood et al., 2005). Both 
receptors are steroid hormone receptors found in the cytoplasm of the cell; however the stress 
response is primarily driven thorough the glucocorticoid receptors. As the free and CBG-bound 
cortisol hormones circulate through various target tissues, free steroid binds specifically to 
intercellular receptors in the cytoplasm of the cells, hence, reducing the free steroid 
concentration and shifting the equilibrium to the disassociation of CBG-bound cortisol in the 
bloodstream. This complex is then transported into the nucleus, and interacts with the DNA of 
the cell. Subsequently, the hormone-receptor ligand complex causes an increase in the 
transcription of specific genes coding for enzymes that in turn affect cellular metabolism, such as 
inducing catabolism of protein within muscles.   
Through this pathway, ultimately, protein in the muscle and bone are broken down, 
gluconeogenesis in liver occurs, and fat reserves are consumed (Sherwood et al., 2005). These 
events all contribute to the production of energy to facilitate the pigs’ body to respond to stress. 
Constant mobilization of energy (i.e. the breakdown of glycogen, production of glucose, and 
breakdown of fats) may at some point create a state of negative energy balance in the young pig 
when it occurs at the cost of energy storage. The lack of available energy further compromises 
the immune system, already suppressed by cortisol. This is of major concern when transporting 
newly weaned pigs to the nursery, as the pigs are mixed with others potentially carrying viral 
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and/or bacterial infections (Holden and Ensminger, 2005). Furthermore, the chronic stress 
response theoretically enhances appetite because expending energy at the cost of energy storage 
eventually stimulates intake for the assimilation of new energy. However, throughout the 
weaning process, stress can also hinder digestive development due to the catabolic effects on 
enzyme production leading to gastrointestinal problems, which further contributes to poor 
growth (Holden and Ensminger, 2005).  
Weaning Stress and Immune Response 
During the weaning process, the naive pig comes into contact with other pigs and new 
environmental factors. If proper management is not practiced, proliferation and introduction of 
pathogens may occur more readily to the incoming herd (Kahn and Line, 2005). Weaned pigs 
also must build new social hierarchies, leading to aggressive behavior and further prolonging the 
stress response. In 2000 and 2006, the USDA’s National Animal Health Monitoring System 
conducted studies on swine health and management practices from a random sample of swine 
production sites with 100 or more pigs in 17 States, representing approximately 94% of pig 
inventory in the United States (USDA, 2008).  This report noted the highest disease rate for both 
years in one or more nursery pigs over a 12-month period were among piglets infected with E. 
coli and Streptococcus bacteria. 
 When young piglets are presented with foreign pathogens, whether transmitted by 
fighting or through contamination (living in unsanitary conditions), their immune system is 
stimulated. The immune system responses described below are summarized from Lancaster 
(2001), Sherwood et al. (2005), and Donaldson (2007). . 
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The first response to an antigen is considered humoral and innate. The three primary 
white blood cells (WBC) involved are macrophages (long-lived mature monocyte that engulf 
foreign material), lymphocytes (B- and T-cells), and neutrophils (very active but short-lived 
phagocytes).  The initial line of immune cell communication is by direct contact with other 
cells/foreign objects through receptor attachment and stimulation. This contact stimulates the 
inflammatory response, a biological response promoting the removal the injurious stimuli while 
also initiating the healing process in the tissue. The inflammatory process is an important part of 
a healthy response to infection; however, if amplified and sustained (especially during a febrile 
response), inflammation can compromise the young pig’s survival. 
Pathogens bind receptors, such as the toll-like receptors, on activated macrophages 
derived from monocytes (Lancaster, 2001; Sherwood et al., 2005; Donaldson, 2007) The 
pathogen is then identified as “foreign,” tagged, and coated with opsin proteins, which increase 
the rate of phagocytosis.  As phagocytosis occurs, mast cells found in connective tissue secrete 
hormonal mediators, such as histamine and chemotaxins, causing vasodilation and increased 
blood flow to the area. Inflammation continues as more phagocytes, other leukocytes (i.e. 
neutrophils, basophils, monocytes, and lymphocytes), and clotting factors migrate to the tissue. 
The secretion of chemotaxins also causes neutrophils and more monocytes stored in the bone 
marrow to migrate into the infected area via diapedisis. Leukocytes begin to proliferate once they 
reach the infected area and phagocytosis increases until the foreign pathogen is destroyed. 
Inflammation ceases once the stimulus has been removed.  
The second type of immune cell communication is through the secretion of 
immunohormones called cytokines, which are responsible for initialing the febrile response 
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(Lancaster, 2001; Sherwood et al., 2005; Donaldson, 2007). The presence of a pathogen quickly 
induces lymphocytes to secrete pro-inflammatory cytokines, which reach the preoptic area of the 
hypothalamus and signal the release of prostaglandins (PGE2), which in turn act locally to 
increase body temperature. Pro-inflammatory cytokines, important in producing fever, include 
interleukin 1 (IL-1), interleukin 6 (IL-6), and tumor necrosis factor alpha (TNF ).  
Tumor necrosis factor alpha acts on the hypothalamus by stimulating the HPA axis 
(described above), further stimulating the stress response. Cortisol stimulates the liver to secrete 
a large number of acute phase reactants such as C-reactive protein, serum amyloid-A, and 
fibrinogen in response to inflammation, as well as enhance the expression of IL-6 receptors in 
the hepatocytes of the liver. Cortisol also promotes IL-6 synthesis in the muscle and fatty tissue, 
which stimulates energy mobilization and leads to an overall increased body temperature. 
Interleukin-1 facilitates the migration of leukocytes to the sites of infection and also raises the set 
point in the hypothalamus thermoregulatory center to a higher temperature, resulting in fever. 
This elevated body temperature creates an unfavorable environment for bacterial growth while 
enhancing the innate immune response. While fever creates a preferred environment for 
immunological reactions, excessive fever can be detrimental to the well being of a young pig, 
leading to wasting and/or dehydration. 
 The lipopolysaccharide (LPS) model of immune challenge is often used when conducting 
studies to measure immune competence in livestock (Johnson and von Borell, 1994; Goujon et 
al., 1995; Mazzocchi et al., 1995). A large molecule composed of only the structural outer 
membrane component of Gram-negative bacteria, LPS acts as an endotoxin and initiates the 
inflammation process and subsequent immune reactions and behavioral effects. Specifically in 
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the pig, LPS has been documented to induce fever (Johnson and von Borell, 1994; Parrott and 
Vellucci, 1998) and reduce feed intake (Webel et al., 1997), typical symptoms and behavior of a 
pathogenic infection. At the cellular level, LPS has been shown to lower circulating levels of 
insulin-like growth factor –1 (IGF-1; Hever et al., 1997), and elevate IL-6, TNF  and cortisol 
levels (Johnson and von Borell, 1994; Webel et al., 1997).   
 The LPS model is a satisfactory immune stimulant in most livestock. However, it does 
not completely demonstrate the physiological changes observed in pigs infected with enteric-
type disease, frequently encountered during the weaning process.  The duration of the effect of 
LPS on the immune system is fairly short (Parrott et al., 1995; Parrott and Vellucci, 1998). In 
contrast, enteric bacterial infections such as Salmonella and E. coli (both common diseases 
among piglets in 2000 and 2006; USDA, 2008) have a gradual onset and symptoms that can last 
for days (Wilcock and Schwartz, 1992).  
 Balaji and colleagues (2000) studied the effects of orally administered Salmonella 
enterical Typhimurim 3 x 10
9 
cfu on the immune system in five week-old piglets. A gradual and 
sustained fever through five days post treatment was noted, unlike fever generated by LPS, 
which resolves within the first 12 hours post treatment (Johnson and von Borell, 1994; Webel et 
al, 1997; Balaji et al., 2000). Also, Salmonella-infected pigs displayed a prolonged surge of 
cortisol (Balaji et al., 2000), whereas a rapid recovery to baseline cortisol concentrations was 
observed in pigs injected with LPS (Webel et al., 1997). Surprisingly, PGE2 and TNF  
concentrations, which are increased during an LPS challenge (Parrott et al., 1995; Webel et al., 
1997; Parrott et al., 1998), remained similar to that of the control groups suggesting that in 
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response to Salmonella, these hormones remained sequestered within the inflamed gut tissue and 
did not contribute to systemic increases leading to a fever (Balaji et al., 2000).  
 While similar results exist between an LPS and Salmonella challenge models, such as 
reduced feeding and growth (Balaji et al., 2000), an LPS model is lacking in demonstrating the 
complete endocrine profile of a weaned pig encountering an enteric and systemic infection.   
Weaning Stress and Appetite 
Sufficient feed intake is needed to enhance the performance, welfare, and health of the 
newly-weaned pig (Le Dividich et al., 2001). Pigs that handle stress poorly weigh less than their 
siblings at weaning and have a lower average daily gain. In extreme cases, stressed pigs can 
experience excessive energy loss and show signs of anorexia (Feuchter, 2004). Increasing feed 
efficiency will not only decrease the growth lag and market age (Kim et al., 2001; Feuchter, 
2004), but will also aid in lowering housing, feeding, and other costs (Gempesaw and Halbrendt, 
1991). Therefore, it is important to understand the physiology of appetite in order to efficiently 
improve feeding behavior. The following discussion of the appetite pathway is a summary from 
reviews by Forbes et al. (2001), Neary et al. (2004), Sherwood et al. (2005), and Wynne et al. 
(2005). 
Many factors such as psychosocial, environmental signals, metabolic condition, and 
adipose concentration, may influence appetite. The major hormones involved in appetite 
regulation are leptin and insulin. Adipose tissue produces leptin, whereas insulin is a pancreatic 
hormone. Leptin and insulin circulate at levels proportional to body fat and exert effects in the 
hypothalamus. Both hormones stimulate and inhibit appetite centers of the hypothalamus, with 
the lateral nuclei controlling hunger, and the ventromedial area controlling satiety. Leptin is 
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reported to play a more central role than insulin for three reasons: 1) during food deprivation, 
plasma leptin concentrations decrease faster than body fat content, forming a more compensatory 
response before energy stores are substantially depleted, 2) leptin deficiency causes severe 
obesity, and 3) leptin acts as a long-term internal measure of energy state (Wynne et al., 2005).  
In satiated or obese animals, higher levels of body fat and other energy reserves exist that 
increase the amount of leptin and insulin produced, leading to a reduction in food intake. Once 
produced, leptin crosses the blood brain barrier to stimulate the catabolic activity of POMC 
neurons and this increases expression of α-melanocyte-stimulating hormone (α-MSH) from the 
arcuate nucleus (Forbes et al., 2001). Alpha-MSH subsequently stimulates CRH from the 
paraventricular nucleus, an appetite suppressant and the major up-regulator of the HPA axis 
(discussed previously). Leptin further inhibits other potent appetite stimulants such as orexin, 
neuropeptide Y (NPY), and agouti-related peptide (AgRP; Sherwood et al., 2005). By decreasing 
orexin from the lateral hypothalamic area and from the perifornical area, the downstream effects 
of leptin (decrease in the secretion of NPY and AgRP in the arcuate nucleus) results in decreased 
feed intake, and if persistent, may lead to anorexia.  
Alpha-MSH and AgRP are competing ligands for the MCR4 receptor. The AgRP 
antagonizes the action of melanocortin agonists, such as α-MSH. In rats, expression of AgRP 
mRNA in the arcuate nucleus of the hypothalamus is decreased subsequent to a stressful event 
(Kas et al., 2005). In turn, this increases the sensitivity of the receptor for -MSH and a 
reduction in FI is observed (Kas et al., 2005).  Emotional stress, such as restraint, and physical 
stress, as exemplified as forced swimming, in rats also increase the POMC gene expression and 
suppress feeding (Liu et al., 2007).  When determining the degree of involvement by the 
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melanocortinergic pathway, antagonists to MC4R blocked the anorectic and anxiogenic effects 
of these stressors, suggesting that this pathway is heavily involved in stress related to anorexia 
(Liu et al., 2007).  
Leptin also exerts effects on other physiological mechanisms. For example, leptin 
decreases the expression of endocannabinoids (Di Marzo et al., 2001), which are endogenous 
lipids that bind cannabinoid receptors. The amount of endocannabinoids produced in the 
hypothalamus is inversely correlated with the amount of leptin carried in the bloodstream. Marzo 
et al. (2001) found that the knockout leptin mice were not only obese, but also had higher than 
normal levels of hypothalamic endocannabinoids.  
During feed restriction, lipid stores in adipocytes become reduced, decreasing the 
production of leptin and insulin (Sherwood et al., 2005). Therefore, appetite-stimulating peptides 
are not suppressed and feed intake is stimulated. This system would be beneficial to the weaned 
pig, given the significant decrease in feed intake following weaning (Feuchter, 2004). However, 
a pig undergoing weaning-related stress on average initially does not eat, suggesting that the 
physiological response to stress overrides any signal to increase intake (Feuchter, 2004; 
Sherwood et al., 2005).  
An additional component of appetite is ghrelin. Ghrelin, secreted from the stomach and 
intestinal tract, is involved in promoting short-term feed intake in anticipation of an expected 
meal (Neary et al., 2004; Wynne et al., 2005). Its actions are exerted in the hypothalamus (at the 
arcuate nucleus) where it induces NPY and AgRP release (Wynne et al., 2005). In recently-
weaned pigs, exogenous ghrelin administration stimulates the growth hormone (GH), insulin, 
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and cortisol axes (Wynne et al., 2005), decreasing weaning anorexia and increasing body weight 
gain.   
Weaning Stress and the Growth Axis 
Another aspect in controlling an efficient growth rate of piglets is through modulation of 
growth hormone (GH). Growth hormone is the primary hormone responsible for regulating 
overall body growth shifting energy stores from fat to muscle and bone. Specifically, GH 
stimulates protein synthesis and amino acid uptake by the muscle tissues to promote muscle 
growth, while promoting lipolysis and inhibiting lipogenesis in adipose tissue (Sherwood et al., 
2005). Effects of GH include increased gluconeogenesis in the liver and decreased protein 
catabolism in muscle (Sherwood et al., 2005). The following discussion of this pathway is a 
summary of Nakazato et al. (2001), Sherwood et al. (2005), Aron et al. (2007), and Gardner et al. 
(2007). 
Growth hormone is a 22-kDa protein released from somatotroph cells in the anterior 
pituitary in response to stimulation by cAMP. Growth hormone is stimulated by growth hormone 
releasing hormone (GHRH), which is secreted from the hypothalamus, specifically, the arcuate, 
paraventricular nucleus and supraoptic nucleus. The release of GHRH is stimulated by eating, 
exercise, or slow-wave sleep (Sherwood et al., 2005).  
Regulation of GH occurs through a number of feedback mechanisms. Many mechanisms 
affect the secretion of GH, but this study focuses on appetite and muscle/bone stimulation 
processes. Ghrelin, stimulated by hunger, enhances GH secretion by 1) acting directly on the 
anterior pituitary and 2) acting indirectly on the hypothalamus to increase GHRH (Nakazato et 
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al., 2001).  Together with GHRH, adenyl cyclase is stimulated and GH production from the 
anterior pituitary is up-regulated (Nakazato et al., 2001).  
Growth hormone is inhibited by growth hormone inhibiting hormone. Growth hormone 
inhibiting hormone is secreted from the arcuate, paraventricular nucleus, and supraoptic nucleus 
of the hypothalamus, and exerts its affects on the neurotransmission and cell proliferation of GH 
via interaction with G-protein-coupled somatostatin receptors (Aron et al., 2007). Growth 
hormone also inhibits its own release, in order to maintain an efficient balance, by decreasing 
GHRH levels secreted from the hypothalamus (Sherwood et al., 2005). 
Peripheral receptors for GH are cytokine receptors, that when activated, dimerize and 
become phosphorylated forming homo- or heterodimers that translocate to the cell nucleus where 
they act as transcription activators to produce insulin-like growth factor, IGF-1 (Gardner and 
Nessinson, 2007), which binds receptors to regulate somatic growth and cellular proliferation 
(Sherwood et al., 2005; Gardner and Nessinson, 2007). Studies have shown that IGF-1 may also 
serve primarily as the negative feedback signal to the hypothalamus and anterior pituitary to 
decrease GH production (Roith et al., 2001). 
 Growth hormone also plays an important role in immunity, as GH receptors are found on 
certain WBC (lymphocytes, monocytes and neutrophils) as well as lymphatic tissues.  Growth 
hormone stimulation of lymphocytes enhances antibody synthesis and basal lymphocyte 
proliferation (as reviewed by Kelley, 1990). Growth hormone also acts on phagocytic cells by 
activating the superoxide release mechanism of macrophages (derived from monocytes), which 
is an oxygen-dependent killing mechanism against invading pathogens (as reviewed by Kelley, 
1990). Granulocyte differentiation of neutrophils occurs more readily upon both GH and IGF-1 
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stimulation (as reviewed by Kelley, 1990). During the stress response, as discussed previously, 
raises in cortisol postpones anabolism, disrupting growth in young animals. Typical of the 
endocrine profile observed during undernutrition (Vance et al., 1992; Straus, 1994), weaning 
increases concentrations of growth hormone (GH) and decreases serum concentrations of IGF-1 
and IGF-2 (Carroll et al., 1998) in piglets. 
Opioids and Stress 
Cortisol levels increase at weaning, as discussed previously, due to stressors such as new 
environmental, social, housing, and food changes (Kojima et al., 2008; Cooper et al., 2009). 
Therefore, the neuro-endocrine HPA axis is also modified during weaning, which stimulates the 
up-regulation of POMC, the precursor for ACTH and endorphins.  
Opioid involvement in the stress pathway appears to be species- and receptor-dependent. 
Pascoe et al. (2008) observed elevated cortisol concentrations in monkeys, and identified the κ-
opioid receptor as the most responsive to stimulation and upregulation of both cortisol and 
ACTH. In humans (Pechnick, 1993), as well as in monkeys (Pascoe et al., 2008), μ-opioid 
receptor agonists inhibit or have no effect on the HPA axis. However, in rodents, the oposite is 
true (Nikolarakis et al., 1987). In post-pubertal gilts, treatment with a μ-opiate receptor 
antagonist (naloxone) increased cortisol levels (Barb et al., 1986).  
Opiates and Immune Function 
The stress of weaning can lead to an immunosuppressed state, leaving the piglets more 
susceptible to disease, as discussed previously. Opioids can modulate immune function directly 
or indirectly, through actions in peripheral tissue such as the adrenal gland or pituitary, or in the 
nervous system (Sibinga and Goldstein, 1988). Opioids can modulate immunological response to 
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tissue injury, microbial invasion, and inflammation. The traditional view that opioids are 
primarily immunosuppressant in nature is derived from experiments using supraphysiologic or 
chronic doses. Opioids actually produce a variety of effects depending on receptor recognition, 
strength, and duration of dose. 
Evolutionarily, opioids originated as immune signaling molecules for microbial invasions 
(Stefano and Kream, 2008). Both invertebrate and vertebrate proenkephalins contain an 
antibacterial peptide called enkelytin (Goumon et al., 1996; Stefano and Kream, 2008). This 
antibacterial peptide is active upon co-secretion with other immune signaling molecules from 
that opioid (Stefano et al., 1998) to instantly attack the pathogen while allowing time for immune 
recruitment.   
Enkephalins are one of three major families of endogenous opioid peptides, which also 
include endorphins and dynorphins. Enkephalins are coded from the proenkephalin gene 
(PENK), and/or cleaved from the POMC product, which is also the precursor for ACTH and -
MSH. Therefore, in situations of stress where the level of ACTH is increased, levels of 
enkephalins also increase slightly. Once enkephalins are produced, they act as neurotransmitters 
and bind one or more of three main subtypes of opioid receptor (µ-, κ-, and δ-opioid receptors). 
Opioid receptors are not only located pre-synaptically, but also post-synaptic as well. Therefore, 
it is important to note that the actions of opioids can vary depending on the location within the 
body (Kandel and Schwartz, 1985). For example, a particular opioid may act as an antagonist to 
the κ-opioid receptors in the brain, and as an agonist at the same type of receptor in the large 
intestines.  
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Wybran et al. (1979) reported one of the first studies measuring opioid activity in the 
immune system of humans. This study showed that met-enkephalins have a stimulatory effect on 
the rosetting of blood lymphocytes, whereas morphine inhibits rosetting. This increase, in turn, 
increased the number of antigens recognized by the lymphocytes (Wybran et al., 1979).  In a 
later study, mouse pre-proenkephalin mRNA and enkephalin peptides were expressed and 
secreted upon activation of T-lymphocytes (Zurawski et al., 1986). 
Opioid peptide production due to pain is beneficial to immune cells during inflammation 
(Stein et al., 1990). Dominika et al. (2009) found that in mice, about 30–40% of stimulated 
immune cells that collect at an injured nerve express three opioid peptides: β-endorphin, met-
enkephalin, and dynorphin A. Each is activated respectively upon the binding to μ-, δ-, and κ-
opioid receptors expressed in nociceptors (Dominika et al., 2009) and inhibit impulse 
propagation of pain. Therefore, upon injury, immune factors sequester and kill invasive 
substances whereas opiates secreted from leukocytes decrease the pain associated with this 
activity.    
Cells of the immune system (neutrophils, monocytes, and lymphocytes) also express 
opioid receptors (Sibinga and Goldstein, 1988; Cabot et al., 2001; Richter et al., 2001; Finley et 
al., 2008). Recent evidence (Finley et al., 2008) suggests that activation of κ-opioid receptors on 
immune cells may induce an anti-inflammatory response while activation of μ-opioid receptors 
induces a pro-inflammatory response. 
Opiates have also been shown to influence factors involved in cytokine signaling 
mechanisms during inflammation. When presented with met-enkephalin at concentrations 
ranging from 1-100 nM, macrophages demonstrated enhanced superoxide production and 
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increased sodium and calcium uptake (Foris et al., 1986), all of which enhance transduction of 
cytokine signaling during inflammation. 
In 1984, Van Epps and Saland found that human monocytes demonstrated positive 
chemotatic effects when presented with beta-endorphins and met-enkephalins. More than 10 
years later, Grimm et al. (1998) also reported that both endogenous met-enkephalin and 
morphine induced human monocyte chemotaxis, but found that it inhibited chemokine-induced 
chemotaxis of human neutrophils. Increasing leukocyte chemotaxis upon an inflammatory 
stimulus will attract leukocytes to that specific site of inflammation more readily. 
Opiates and Appetite Regulation 
The growth lag seen among recently weaned pigs is well recognized and clearly 
associated with a reduction in feed intake (Bark et al., 1986; McCracken et al., 1995). Mu-opioid 
agonists stimulate appetite in many ways. Mu-opioids have been shown to up-regulate the 
activity of appetite stimulators such as AgRP (Hagan et al., 2001; Brugman et al., 2002) and 
NPY (Kotz et al., 1993; Pomonis et al., 1997; Dodo et al., 2005). They are also known to 
decrease the synthesis of certain appetite suppressors such as -MSH, one product of the POMC 
gene (Wardlaw et al., 1996). Opioids can also decrease the expression of the MC4R. 
Opiates and Growth  
Opioids are known to stimulate GH secretion in rats when given centrally (Chihara et al., 
1978) or peripherally (Krulich et al., 1986). Vaccarino and Taub (1997) provided evidence 
showing opioid feeding signals arise from the arcuate nucleus and are linked with the 
suprachiasmatic nucleus and medial pre-optic area of the hypothalamus. Downstream signaling 
initiates growth hormone releasing-factor (GRF) feeding mechanisms, thus, allowing for both 
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central and peripheral GRF integrations (i.e. appetite and growth). Further, research also 
indicates opiates stimulate GH signals which are transmitted through μ-opioid receptors and 
inhibited by κ-opioid receptors (Krulich et al., 1986), However, this pathway needs further 
investigation.  
Opioid Antagonists 
When measuring opioid-mediated activity, researchers have used the strong opioid 
antagonist naloxone (NAL; Sibinga and Goldstein, 1988). Naloxone binds opioid receptors with 
high affinity, out-competing opioids for access to the receptor active sites, and blocking receptor 
activation (Kosterlitz and Watt, 1968). Naloxone has its greatest affinity for the µ-opiate 
receptor; however, at high levels, it also has the ability to antagonize κ- and δ-opioid receptors 
(Sibinga and Goldstein, 1988; Taub et al., 1991; Kulkarni -Narla et al., 2001). 
Syndyphalin-33 
 
Syndyphalin-33 (SD-33) is a synthetic enkephalin designed and first synthesized and 
described by Kiso and coworkers in 1981. The technical annotation of SD-33 is Tyr-Dmet(O)-
Gly-MPA, or more specifically, tyrosine-methionine sulfoxide-glycine-methylphenethylamide. 
Designed as a small functional fragment of met-enkephalin, SD-33 exerts prolonged analgesic 
activity (Kiso et al., 1981). It is important to note that specific actions of SD-33 are still largely 
unknown and may vary somewhat from the actions of enkephalins in general. 
Recent SD-33 Research 
Given the previous analyses, it is plausible that SD-33 may act as an appetite stimulator 
to increase feed intake, reduce the post-weaning growth lag, and help the piglet overcome the 
negative effects of stress.  
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Buonomo et al. (1991) reported that SD-33 stimulated GH secretion in rats, pigs, and 
sheep when administered by intravenous (i.v.) and subcutaneous (s.c.) injections and by oral 
gavage. Rats and hogs (40 kg) were treated with s.c. injections of SD-33. In rats, peak levels of 
GH were noted at 30 minutes post injection in a dose-dependent fashion. The authors observed 
an 8-fold increase in GH secretion within 30 minutes postinjection (~16 ng/mL) and a 2-fold 
increase by 90 minutes postinjection (~6 ng/mL) in hogs that received a single s.c. injection of 
0.5 mol/kg SD-33. Using an oral gavage of SD-33 in a rat model, GH levels peaked in a dose-
responsive manner 30 minutes postinjection (1.5, 2.75, 5-fold by 1.0, 10, and 100 mol/kg of 
SD-33, respectively) and remained elevated until 2 hours postinjection. In hogs given a 2.0 
mol/kg oral dose, GH concentrations were increased 2.2 fold within 30 minutes postinjection 
and remained elevated until 2 hours postinjection.  
Overall, the response of GH to i.v. injections of SD-33 in sheep was immediate and 
transitory; however, the s.c. and oral administration resulted in a sustained increase in GH 
concentrations lasting approximately 1.5 hours for s.c. injections and 1-2 hours for oral 
administration. Both of these effects were blocked by naloxone (Buonomo et al., 1991). 
Obese et al. (2007) used an adult wether model to determine the effect of SD-33 on feed 
intake.  The authors observed that a single i.v. injection of SD-33 (0.05 and 0.1 mol/kg) 
increased cumulative feed intake over a 48-hour period in a dose-dependent manner. The higher 
dose yielded increased feed intake over 24 hours relative to controls. No increase in feed intake 
was observed in wethers administered 0.1 nmol/kg SD-33 i.v. injected twice (five minutes apart), 
when concomitantly given 0.1 ug/kg LPS. The authors then determined that the ability of a 
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single i.v. injection of SD-33 to increase feed intake was attenuated by naloxone, and speculated 
that the actions of SD-33 may be mediated through the μ-opioid receptor.   
These two experiments observe immediate of affect of SD-33 on GH concentrations but 
delayed effect (24-48 hours) on feed intake. Also, while this published data suggests that SD-33 
is a μ-opioid based on the ability of naloxone to block its actions, the possibility that this 
molecule may also bind one of the other opioid receptor subtypes must be considered.  
The experiments described hereafter attempt to characterize the effects of SD-33 on 
growth, appetite, and immune function in the newly-weaned pig. 
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CHAPTER TWO: 
Effects of syndyphalin-33 on feed intake and circulating measures of  
growth hormone, cortisol, and immune cell populations in the recently-weaned pig 
 
Abstract 
The synthetic met-enkephalin syndyphalin-33 (SD-33) increases feed intake in sheep, and 
transiently increases circulating growth hormone (GH) concentrations in sheep, rats and pigs. 
Two experiments were performed to evaluate the effects of SD-33 on recently-weaned pigs. In a 
preliminary experiment, pigs were administered either SD-33 (0.5 μmole/kg, given IM) or saline 
immediately prior to a 3 h transport and subsequent placement into group pens. Treatment with 
SD-33 increased (P = 0.01) daily feed intake; cumulatively, pen intake over 7 d postweaning 
tended (P < 0.06) to be greater than in control pens. In the second experiment, pigs were weaned 
and fitted with jugular catheters. The following day, pigs were treated with either SD-33 or 
saline as described above. Transient increases (P < 0.05) in circulating concentrations of GH (at 
1 and 1.5 h postinjection) and cortisol (at 3.5 and 4 h postinjection) were observed in pigs treated 
with SD-33 relative to controls. No difference in feed intake was observed between treatments 
over 4 d postinjection. Increased (P < 0.05) numbers of circulating neutrophils, lymphocytes and 
monocytes were observed in both treatment groups over 4 d postinjection, and treatment with 
SD-33 tended (P < 0.07) to selectively increase monocyte numbers. Although SD-33 has 
potential to be used to increase feed intake and decrease the negative effects of stress during 
weaning in pigs, further investigation is needed to better understand the timing of effect and to 
rule out possible immunosuppressive effects.
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Introduction 
Syndyphalin-33 (Tyr-D-Met(O)-Gly-N-methylphenethylamide; SD-33) is a synthetic 
opioid capable of prolonged analgesic activity (Kiso et al., 1981).  In 1991, Buonomo and co-
workers administered SD-33 (orally, subcutaneously and intravenously) to pigs, rats and sheep. 
They found that the SD-33 treatment resulted in transient increases of circulating concentrations 
of growth hormone (Buonomo et al., 1991). More recently, in 2007, SD-33 was found to increase 
feed intake (FI) in adult sheep 48 h after intravenous administration (Obese et al., 2007). This 
effect was lost when the animals were inoculated with a lipopolysacharide challenge at the time 
of SD-33 administration (Obese et al., 2007). In each of these three studies, the effects of SD-33 
relating to analgesia, circulating GH concentrations, and FI were all blocked by naloxone, 
suggesting that the observed effects were mediated (at least in part) through the -opioid 
receptor. The discrepancy in the timing of onset of the various effects of SD-33, (rapid 
stimulation of analgesia and growth hormone, but a prolonged interval before feed intake was 
increased) is not yet understood, but may be due to difference in complexity of affected 
pathways and/or differences in age/species of the animal models used.  
In recently weaned pigs, weaning stress leads to decreased FI, increased susceptibility to 
disease, and poor growth, all of which are well-documented (Matteri et al., 2000; Kojima et al., 
2007; Kojima et al., 2008). These responses to the stress of weaning often result in a growth lag, 
ultimately delaying production gain and profitability. Stress can also contribute to severe 
illnesses and even mortality, particularly in conditions of sub-optimal herd health or 
management. Through its various effects, particularly on FI, SD-33 may offer some protection 
  
24 
 
 
during the weaning process by increasing overall health and well-being during this critical 
period.  
Two experiments that investigate the potential for SD-33 to improve the post-weaning 
growth lag in recently weaned pigs. The first experiment describes a preliminary trial 
characterizing on the effects of SD-33 on FI and growth. The second experiment concentrates on 
the acute affects of SD-33 on the growth, stress, and immune axes. 
Materials and Methods 
Animals and Diets 
All animal procedures were reviewed and approved by the University of Tennessee 
Animal Care and Use Committee. Crossbred pigs (Landrace x Duroc x Hampshire) were 
farrowed in standard farrowing pens and processed according to standard University of 
Tennessee Experiment Station practices at 4 to 7 d of age. Procedures for processing included 
needle teeth clipping, tail docking, iron supplementation, ear tagging, and castration of males. 
The pigs were kept in farrowing pens with their dams until weaning, with creep feed (Diet 
554PE, Tennessee Farmers Cooperative, LaVergne, TN) available 10 d after birth until weaning. 
Experimental Design 
Exp. 1. On d 0, 12 pigs (6 barrows and 6 gilts, 24 ± 1 d of age, 7.08 ± 0.22 kg) were 
weighed and randomly allocated by gender and BW to the following treatment groups: SD-33, 
receiving 0.5 μmole/kg SD-33 (Bachem, Torrance, CA) in saline by a single i.m. injection of 0.5 
mL or less; or VEH, receiving a single i.m. injection of 0.5 mL saline. Pigs were removed from 
their sows, administered their respective treatments, mixed, and subjected to a 3 h transport in a 
vented, bedded livestock trailer. Upon return, 3 pigs were grouped by gender into pens (1.3 m
2
), 
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2 pens per treatment group. Nursery feed (described above) and water were provided ad libitum. 
Pen FI and individual BW were recorded daily through d 7. 
Exp. 2. Sixteen pigs (8 barrows and 8 gilts, 24 ± 1 d of age, 7.66 ± 0.08 kg) were 
removed from their dams, weighed and fitted nonsurgically with an indwelling jugular 
angiocatheter as described previously (Carroll et al., 1999). Briefly, an angiocatheter was 
inserted into the jugular vein while the pigs were immobilized with isoflurane for approximately 
10 min. Immediately after catheter placement, pigs were placed in individual pens (1.3 m
2
) with 
nursery feed and water provided ad libitum. Approximately 24 h following cannulation, pigs 
were weighed and allocated by gender and weight to 2 treatment groups (SD-33 and VEH) as 
described above. One gilt was removed from the study at this time due to failure of catheter 
patency. Serial blood sampling was performed such that 4 mL of blood was collected every 30 
min for 6 h. Immediately following collection of the initial blood sample, pigs were administered 
their respective treatments. Blood (1 mL) was also collected at 0, 24, 48, 72 and 96 h 
postinjection for determination of circulating white blood cell (WBC) concentrations. The 
experiment was comprised of two replicates (8 pigs each). 
Blood Collection and Analyses 
For hormone assays, blood was collected into heparinized (90 USP sodium heparin) tubes 
and centrifuged at 2,000 x g for 10 min. The plasma was stored at –20°C until analyzed for GH 
and cortisol. For WBC count and differentials, blood was collected in tubes spray-coated with 
5.4 mg of K2 EDTA and immediately shipped on ice to a commercial clinical laboratory (Vet 
Path Labs, Tulsa, OK). The results reported are total WBC concentration (WBC/μL), which 
consists of the concentration of neutrophils, lymphocytes, and monocytes as well as the 
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percentage of neutrophils, lymphocytes, and monocytes relative to total WBC concentration. The 
total plasma cortisol concentration was determined by RIA as previously reported (Scroggs et al., 
2002). Cortisol concentration was expressed as nmole/L. Intra- and inter-assay CV were 6.6 and 
12.9 % for low (110 nmol/L), 8.3 and 4.8 % for medium (325 nmol/L), and 5.5 and 7.3% for 
high (772 nmol/L) cortisol standards. The sensitivity for the assay was 5.5 nmol/L. The plasma 
GH concentration (ng/mL) was determined by a commercially available RIA specific for porcine 
GH (Linco, St. Charles, MO). Intra- and inter-assay CVs were 17.6 and 19.8% for low (4.16 
ng/mL), and 14.1 and 17.9 % for high (28.89 ng/mL) GH standards. The sensitivity of the assay 
was 1 ng/mL. 
Statistical Analyses 
The variables were analyzed with a mixed model ANOVA, using a model for a 
randomized block design. For Exp. 1, pen was the experimental unit for FI, and pig was the 
experimental unit for BW. In Exp. 2, pig was the experimental unit. For all variables except 
cumulative FI and gain, the model included treatment as a main effect with repeated measures. 
Square root transformations were performed on GH and cortisol data to preserve homogeneity of 
variance. For GH and cortisol, only animals with a complete set of data were included in the 
analysis (VEH: n = 7; SD-33: n = 4), as several cannulae failed during the sampling period. Least 
squares means were compared using Fisher’s protected least significant difference. A 
significance level of P < 0.05 was used for all testing; trends where P < 0.10 were also reported. 
All graphical and textual descriptions of results are reported as raw means and standard errors. 
For Exp. 2, preliminary analysis detected no replicate effect, and so replicate was removed from 
the model. 
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Results 
Feed Intake and Growth 
Exp. 1. The treatment of the pigs with a single injection of SD-33 at the time of weaning 
resulted in increased (P < 0.01) daily FI (Figure 1A). Cumulatively, pen intake over 7 d 
postweaning in SD-33 pens (10.68 ± 0.58 kg) tended (P = 0.06) to be greater than in VEH pens 
(7.93 ± 0.41 kg; data not shown). Although weaning resulted in a loss of BW 1 d postweaning 
for both treatment groups (P < 0.05), BW did not differ between the 2 treatment groups at any 
time (Figure 1B). 
Exp. 2. Feed intake of both VEH and SD-33 pigs increased over time (P < 0.0001), but 
did not differ between treatment groups at any time (Figure 2A). Cumulative FI was not different 
between SD-33 pigs (1.14 ± 0.16 kg) and VEH pigs (0.89 ± 0.11 kg; data not shown). There 
were no differences in BW due to treatment at any time (Figure 2B). Cumulative weight gain 
over 4 d postinjection did not differ between SD-33 pigs (0.81 ± 0.15 kg) and VEH pigs (0.96 ± 
0.09 kg; data not shown). 
Plasma GH and Cortisol 
A transient increase (P < 0.05) in plasma concentrations of GH was observed at 1 and 1.5 
h postinjection in the SD-33 pigs relative to the VEH group (Figure 3A). By 2 h postinjection, 
GH concentrations were not different between treatment groups and remained so for the 
remainder of the study. Plasma concentrations of cortisol were greater (P < 0.05) in SD-33 pigs 
at 3.5 and 4 h postinjection; by 4.5 h, cortisol concentrations in the two treatment groups no 
longer differed (Figure 3B). 
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Circulating WBC Populations 
Overall, WBC concentrations, as well as individual populations of neutrophils, 
lymphocytes and monocytes, were elevated on d 1 to 4 postinjection relative to the pre-injection 
levels in both SD-33 and VEH pigs (Figure 4A-D). A trend (P = 0.07) was noted where 
monocyte numbers were increased in SD-33 pigs relative to the VEH pigs on d 1 to 4 
postinjection (Figure 5D). This increase in monocytes resulted in a decrease (P < 0.05) in the 
percentage of WBC that were lymphocytes in SD-33 pigs (31.88 ± 4.76) relative to controls 
(47.87 ± 5.49) at 2 d postinjection (Figure 5B). 
Discussion 
The variables investigated in recently weaned pigs were feed intake (FI), body weight 
(BW), circulating levels of growth hormone (GH), plasma cortisol, and individual white blood 
cells (WBC). Each will be further discussed.  
Feed Intake 
The inhibition of piglet growth rate caused by weaning is well recognized and clearly 
associated with reduced FI (Bark et al., 1986; McCracken et al., 1995). In our preliminary 
experiment (Exp. 1.), a clear and robust increase in FI was seen in weaned and transported pigs 
that received a single injection of SD-33 at weaning. In agreement with observations made in 
adult sheep (Obese et al., 2007), this increase did not manifest until 2 d after administration. The 
continued increase in FI throughout the experiment is intriguing. While it is possible that this 
may arise out of a long-term stimulatory action of SD-33 on appetite, the mechanism behind the 
prolonged effect is unclear. In Exp. 2, no significant increase in FI was noted in treated animals, 
although a numerical pattern was evident. The pigs in the second experiment were administered 
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SD-33 the day after they were weaned and cannulated, and these pigs were not subjected to 
transportation. The amount, duration and type of stress experienced by the pig may all modulate 
the physiological response to SD-33. 
The effects of SD-33 in FI and GH can be blocked by naloxone, leading to the 
speculation that SD-33 is a μ-opioid receptor agonist (Buonomo et al., 1991; Obese et al. 2007). 
Mu-opiates upregulate the activity of appetite stimulators such as agouti-related peptide (AGRP; 
Hagan et al., 2001; Brugman et al., 2002) and neuropeptide Y (NPY; Kotz et al., 1993; Pomonis 
et al., 1997; Dodo et al., 2005). They are also known to decrease the synthesis of certain appetite 
suppressors such as -melanocyte stimulating hormone ( -MSH), one product of the 
proopiomelanocortin (POMC) gene (Wardlaw et al., 1996). Opioids can also decrease the 
expression of the melanocortin-4 receptor (MC4R), hence lowering its binding activity to AGRP 
and -MSH (Chaki et al., 2005). 
Stress, too, alters appetite regulators. In rats, the expression of AGRP mRNA in the 
arcuate nucleus of the hypothalamus is decreased subsequent to a stressful event (Kas et al., 
2005). In turn, this increases the sensitivity of the receptor for -MSH and a reduction in FI is 
observed (Kas et al., 2005).  Emotional stress such as restraint and physical stress such as forced 
swimming in rats also increased the POMC gene expression and suppressed feeding (Liu et al., 
2007).  When determining the degree of involvement by the melanocortinergic pathway, 
antagonists to MC4R blocked the anorectic and anxiogenic effects of these stressors, suggesting 
that this pathway is heavily involved in stress related to anorexia (Liu et al., 2007). Taken 
together, these observations suggest that the effectiveness of SD-33 in increasing FI may depend 
on the severity of the stress the animal is experiencing at that time.  
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Appetite and Body Weight 
For both Exp. 1 and Exp. 2, increases in BW did not accompany the increases in FI in 
SD-33 pigs. Thus, the elevated energy from the enhanced feed intake may be partitioned toward 
another physiological activity other than growth.  It is important to note that opioids have 
systemic actions that include such processes as lipolysis in humans (Vettor et al., 1993) and in 
rabbits (Richter et al., 1983). Opioids are also known to increase metabolism in rats by an 
enhancing the release of triiodothyronine and thyroxine (Tal et al., 1984; Baumgartner et al., 
1998). In the case of the newly-weaned pig, feed efficiency is not as much of an issue as is health 
and general well-being, particularly for the first few days after weaning. 
Growth Hormone  
Buonomo et al. (1991) observed immediate increases in GH levels in wethers (given 
0.05, 0.10, or 0.20 μmole/kg SD-33 i.v.), rats (given 0.5, 1.0, or 2.0 μmole/kg SD-33 s.c.), and 50 
kg barrows (given 0.50 μmole/kg SD-33 s.c.). This effect was also observed when 50 kg barrows 
were given SD-33 orally, but the increase was less intense and somewhat delayed compared to 
subcutaneous administration, where the peak GH concentration was observed as early as 30 min 
postinjection. In our study, treatment with SD-33 resulted in a transient increase in circulating 
concentrations of GH at 1 and 1.5 h postinjection. We observed increases of an amplitude similar 
to that reported for barrows treated with subcutaneous administration of SD-33, but the timing of 
the effect was more similar to the results reported for barrows administered SD-33 as an oral 
dose (Buonomo et al., 1991). We conclude that the route of administration may alter the profile 
of the acute response.   
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Vaccarino and Taub (1996) found evidence showing opioid feeding signals arise from the 
arcuate nucleus and are linked with the suprachiasmatic nucleus and medial preoptic area of the 
hypothalamus. Downstream signaling initiates growth hormone releasing-hormone (GHRH) 
feeding mechanisms, thus, allowing for both central and peripheral GHRH integrations (i.e. 
appetite and growth). Opioid-stimulated GH signals are thought to be transmitted through -
opiate receptors and inhibited by -receptors (Krulich et al. 1986), further evidence that SD-33 
works through -opiate receptors.  
Cortisol 
Cortisol is the primary glucocorticoid secreted during stress, involved in the 
hypothalamic-pituitary-adrenal (HPA) axis. Cortisol also has widespread effects in other energy 
producing events such as promoting fat deposits (a desirable trait for swine yield), as well as in 
immune function, acting as an anti-inflammatory. Cortisol concentrations are normally increased 
for at least the first 24 h postweaning, presumably due to the stress associated with 
transportation, social mixing, and maternal separation (Kojima et al., 2008, Cooper et al., 2009). 
The baseline cortisol values in the current study (1 day postweaning) represent this elevated 
stress status. 
We observed an increase in plasma cortisol concentrations in SD-33 pigs (relative to 
VEH pigs) at 3.5 and 4 h postinjection. Effects of exogenous opioids on the HPA axis appear to 
be species dependent.  Pascoe et al. (2008) observed elevated cortisol concentrations in monkeys, 
and identified the -receptor as the most responsive to stimulation and upregulation of both 
cortisol and ACTH. In humans (Pechnick, 1993) and monkeys (Pascoe et al., 2008), μ-opioid 
receptor agonists inhibit or have no effect on the HPA axis. However, in rodents, the opposite is 
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true (Nikolarakis et al., 1987). In post-pubertal gilts, treatment with a μ-opiate receptor 
antagonist (naloxone) increased cortisol levels (Barb et al., 1986).  
Some have speculated that -opioids exert effects on circulating cortisol concentrations 
through central regulation of corticotrophin-releasing hormone (CRH; Buckingham and Cooper, 
1986; Nikolarakis et al., 1987). In our study, we did not observe an effect of SD-33 on 
circulating cortisol concentrations until 3 h postinjection. This may be a reflection of the time 
needed to translate an opioid’s stimulatory effect on CRH in the hypothalamus (Yamauchi et al., 
1997) through an increase in ACTH from the anterior pituitary before the end result, stimulation 
of cortisol release from the adrenal glands, can be observed. 
Glucocorticoids also have a stimulatory effect on feed intake through their feedback to 
the hypothalamus. CRH-containing neurons release endocannibinoids, which act to increase feed 
intake upon stimulation of glucocorticoids (Dallman, 2003; Di et al, 2003). This may indicate yet 
another mechanism by which SD-33 acts to increase feed intake.  
Immune Cell Populations 
We observed increases in WBC, neutrophils, lymphocytes and monocytes over time in 
both SD-33 and VEH treatment groups. Previously, we have shown that circulating immune cell 
populations increase at 1 d postweaning and return to pre-weaning levels by 7 d postweaning 
(Kojima et al., 2008, Cooper et al., 2009), but we had not monitored these populations at any 
time in between. It would appear from our current data that immune cell populations continue to 
increase for several days postweaning. This may indicate prolonged inhibition of chemotaxis by 
cortisol and a progressive accumulation of cell numbers.  
  
33 
 
 
Treatment with SD-33 appeared to selectively increase monocyte numbers through 4 d 
postinjection, although the response did not reach statistical significance. Opioids are known to 
have immuno-modulary functions, and cells of the immune system (neutrophils, monocytes, and 
lymphocytes) express opioid receptors, as reviewed by Finley et al. (2008). Grimm et al. (1998) 
reported that endogenous met-enkephalin and morphine induced monocyte chemotaxis, but 
inhibited chemokine-induced chemotaxis of human neutrophils; these responses were blocked by 
naloxone. Recent evidence (Finley et al., 2008) suggests that activation of -opioid receptors 
may induce an anti-inflammatory response while activation of µ-opioid receptors induces a pro-
inflammatory response. Naloxone, although primarily known as a µ-opioid receptor antagonist, 
also antagonizes - and -opioid receptors. While most of the published data suggests that SD-33 
is a µ-opioid, the possibility that this molecule may also bind one of the other opioid receptor 
subtypes must be considered. 
Implications 
The synthetic enkephalin SD-33 has potential to be used as an agent to increase feed 
intake and decrease the negative effects of stress during weaning in pigs, but further 
investigation is needed to better understand the timing of effect, and to rule out any 
immunosuppressive effects which would be detrimental to the animal’s well-being.  
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Figure 1. A) Feed intake in pens of pigs injected with saline (VEH; light bars) or 0.05 μmole/kg 
syndyphalin-33 (SD-33; dark bars) immediately prior to weaning (n = 2 pens). B) Body weight 
of VEH and SD-33 pigs (n = 6). For both graphs, raw means with SE are shown. 
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graph, means with different letters differ (P < 0.05). 
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Figure 2. A) Feed intake of pigs injected with saline (VEH; n = 7; light bars) or 0.05 μmole/kg 
syndyphalin-33 (SD-33; n = 8; dark bars) 1 d after being weaned and fitted with jugular 
cannulae. B) Body weight of VEH (n = 7) and SD-33 (n = 8) pigs. For both graphs, raw means 
with SE are shown. 
a-d 
Within a graph, means with different letters differ (P < 0.05). 
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Figure 3. A) Circulating concentrations of A) GH and B) cortisol in plasma of pigs injected with 
saline (VEH; n = 7; ■ ) or 0.05 μmole/kg syndyphalin-33 (SD-33; n = 4; ●) 1 d after being 
weaned and fitted with jugular cannulae. Injections occurred immediately after time 0. For both 
graphs, raw means with SE are shown. 
*
Within a time point, means of VEH and SD-33 
treatments differ (P < 0.05). 
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Figure 4. Circulating populations of A) total white blood cells (WBC), B) neutrophils, C) 
lymphocytes, and D) monocytes in pigs injected with saline (VEH; n = 7; light bars) or 0.05 
μmole/kg syndyphalin-33 (SD-33; n = 8; dark bars) 1 d after being weaned and fitted with 
jugular cannulae. For all graphs, raw means with SE are shown. 
a,b 
Within a graph, means with 
different letters differ (P < 0.05). 
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Figure 5. Percentages of total circulating white blood cells that are A) neutrophils, B) 
lymphocytes and C) monocytes in pigs injected with saline (VEH; n = 7; light bars) or 0.05 
μmole/kg syndyphalin-33 (SD-33; n = 8; dark bars) 1 d after being weaned and fitted with 
jugular cannulae. For all graphs, raw means with SE are shown. 
* 
Within a time point, means of 
VEH and SD-33 treatments differ (P < 0.05).
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CHAPTER THREE: 
Effects of Syndyphalin-33 on immune function during a  
Salmonella challenge in recently weaned pigs 
 
Abstract 
This experiment was performed to evaluate the effectiveness Syndyphalin-33 (SD-33) 
has when recently weaned pigs are inoculated with the enteric pathogen, Salmonella enterica 
(SALM). On d 0, pigs (8 barrows and 6 gilts, 24 ± 1 d of age, 8.43 ± 0.82 kg) were weaned and 
fitted with jugular catheters. The following day, pigs were administered either SD-33 (0.5 
μmole/kg, given i.m.) or SALM (oral dose of 5 x 109 CFU) as the treatment group, and either 
saline (VEH; 0.5 mL, given i.m.) or sterile broth (CON; 3 mL oral gavage) in a factorial 
arrangement such that 4 treatment groups existed: VEH+CON (n = 4), SD-33+CON (n = 3), 
VEH+SALM (n = 3), and SD-33+SALM (n = 4). There were no differences in feed intake (FI) 
or body weight (BW) among the SALM treated animals over time (P > 0.05). Cumulatively, FI 
among the SD-33+CON pigs was greater (P < 0.05) compared to the SD-33+SALM pigs. Over 4 
d postinjection, white blood cell (WBC) populations increased (P < 0.05). On d 2 postchallenge, 
circulating neutrophils and lymphocytes were lower (P < 0.05) in VEH+SALM but not in SD-
33+SALM pigs relative to VEH+CON and SD-33+CON pigs, demonstrating the ability of SD-
33 to abrogate the affect of Salmonella; partial blocking was seen in both circulating neutrophil 
and lymphocyte populations. Also, on d 2 postchallenge, circulating monocyte populations were 
greater (P < 0.05) in pigs receiving SD-33 relative to controls regardless of Salmonella 
treatment. The results of this preliminary study suggest that the opioid SD-33 may act as an anti-
inflammatory in recently weaned pigs.
  
45 
 
 
Introduction 
The process of weaning pigs involves many stressors, and the proliferation and 
introduction of a pathogen occurs more readily in new arrivals to the nursery facility (Kahn and 
Line, 2005). Syndyphalin-33 (Tyr-D-Met(O)-Gly-N-methylphenethylamide; SD-33) is a 
synthetic opioid with prolonged analgesic activity (Kiso et al., 1981), and has the ability to 
increase feed intake (FI) in adult wethers (Obese et al., 2007). The effect on FI was observed in 
wethers 48 h after intravenous administration of SD-33, but was not observed in wethers 
subjected to both SD-33 and a lipopolysaccharide challenge. Recently, we have observed 
increased FI in healthy recently-weaned pigs given a single intramuscular injection of SD-33 at 
weaning.  
Exposure of pigs to the bacteria, Salmonella enterica, simulated a common immune 
challenge pigs frequently encounter during weaning (Baliji, et al., 2000). The typical 
lipopolysaccharide (LPS) challenge initiates a well-characterized inflammatory response and 
fever (Johnson and von Borells al. 1994; Parrott and Vellucci 1998), but the response is only 
quick and short-lived (Parrott et al. 1995; Parrott and Vellucci, 1998). The response to a 
Salmonella challenge, however, is gradual in onset, and sustained for up to 4 d (Wilcock and 
Schwartz, 1992). The USDA’s National Animal Health Monitoring System stated in 2008 that 
such enteric diseases rank the highest among diseases frequently observed in weaned pigs 
(USDA 2008).  
As an opioid agonist capable of stimulating appetite and inducing analgesia, SD-33 may 
offer some protection during the weaning process by increasing the overall health and well-being 
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of pigs during this critical period. Recent reports suggest that opioids may modulate immune 
function through altering chemotaxis and immune cell function.  
The objective of this experiment was to characterize the effect of SD-33 on immune cell 
populations with and without a concurrent inoculation with a common enteric pathogen, 
Salmonella.  
Materials and Methods  
Animals and Diets 
All animal procedures were reviewed and approved by the University of Tennessee 
Animal Care and Use Committee. Crossbred pigs (Landrace x Duroc x Hampshire) were 
farrowed in standard farrowing pens and processed according to usual University of Tennessee 
Experiment Station practice at 4 to 7 d of age. Procedures for processing included needle teeth 
clipping, tail docking, iron supplementation, ear tagging, and castration of males. The pigs were 
kept in farrowing pens with their dams until weaning, with creep feed (Diet 554PE, Tennessee 
Farmers Cooperative, LaVergne, TN) available 10 d after birth. 
Experimental Design 
Fourteen pigs (8 barrows and 6 gilts, 24 ± 1 d of age, 8.43 ± 0.82 kg) were removed from 
their sows, weighed and fitted nonsurgically with an indwelling jugular angiocatheter as 
described previously (Carroll et al., 1999). Briefly, an angiocatheter was inserted into the jugular 
vein while the pigs were immobilized with isoflurane for approximately 10 min. Immediately 
after catheter placement, pigs were placed in individual pens (1.3 m
2
) with nursery feed and 
water provided ad libitum. Approximately 24 h following cannulation, pigs were weighed and 
allocated by gender and weight to 4 treatment groups in a 2 x 2 factorial design: SD-33+SALM 
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(n = 4), VEH+SALM (n = 3), SD-33+CON (n = 3), and VEH+CON (n = 4). Pigs in the SD-33 
treatment groups received 0.5 μmole/kg SD-33 (Bachem, Torrance, CA) in saline by a single i.m. 
injection of 0.5 mL or less, and pigs in the VEH groups received a similar injection of 0.5 mL 
saline. Pigs in the SALM groups were inoculated with an oral dose of 5 x 10
9
 CFU of live 
Salmonella enterica serovar Typhimurium culture in a volume of 3 mL (Strain 798-4232, 
National Animal Disease Control, USDA, Ames, IA) as described previously (Ebner et al., 2000 
and Mathew et al., 2005). Pigs in CON groups received a 3 mL oral gavage of sterile broth.  
 Feed intake (FI) and body weight (BW) were measured and blood was collected daily at 
0 (immediately prior to treatment), and 24, 48, 72 and 96 h postinjection.  
Blood Collection Analysis 
Blood for determining white blood cell (WBC) count and differentials was collected in 
tubes spray-coated with 5.4 mg of K2 EDTA and immediately shipped on ice to a commercial 
clinical laboratory (Vet Path Labs, Tulsa, OK). The results reported are total WBC concentration 
(WBC/μL), which consists of the concentration of neutrophils, lymphocytes, and monocytes as 
well as the percentage of neutrophils, lymphocytes, and monocytes relative to total WBC 
concentration.  
Statistical Analysis 
The variables were analyzed with a mixed model ANOVA, using a model for a factorial 
design. Pig was the experimental unit. For all variables, the model included treatment (+/- SD-
33) and challenge (+/- SALM) as main effects, along with the interaction between main effects, 
with repeated measures when appropriate. Initial body weight (weaning weight prior to 
cannulation) was included as a covariate for all analyses. Square root transformation was 
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performed as necessary to maintain homogeneity of variance. For variables presented as repeated 
measures, post-hoc analysis was conducted for each separate time-point (T-test). A significance 
level of P < 0.05 was used for all testing; trends where P < 0.10 were also reported. All graphical 
and textual descriptions of results are reported as raw means and standard errors.  
Results 
Feed Intake:  
Daily FI increased (P < 0.0001) in each of the 4 d measured in all treatment groups 
(Figure 1A). Treatment with SALM resulted in an overall decrease (P < 0.05) in FI, particularly 
on d 3 post challenge (P < 0.05). An interaction occurred such that at 2 d post challenge, SD-
33+SALM pigs consumed very little feed while SD-33+CON pigs consumed the greatest amount 
of feed (P < 0.05). Cumulative FI over the 4 d trial was decreased (P < 0.05) in SALM pigs 
relative to CON pigs (Figure 1B). There was a trend (P = 0.065) for a treatment interaction such 
that the effect of Salmonella was more evident in SD-33 (0.27 + 0.09 kg) pigs than in VEH (0.66 
+ 0.17 kg) pigs. 
Body Weight 
Cumulative weight gain was decreased (P < 0.05) in SALM pigs relative to CON pigs 
(Figure 2). A trend (P = 0.067) was observed such that SD-33+SALM pigs were less affected 
than VEH+SALM pigs, gaining 0.05 + 0.27 and losing 0.13 + 0.19 kg over the 4 d trial period, 
respectively. 
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Overall Immune Cells 
Total WBC numbers increase (P ≤ 0.0001) through d 4 (Figure 3). Populations of WBC 
were increased (P ≤ 0.0001) in SD-33 pigs relative to VEH pigs. On d 2, WBC concentrations 
were lower (P < 0.05) in VEH+SALM pigs, but not SD-33+SALM pigs, relative to CON pigs.  
Circulating neutrophil concentrations increased (P < 0.0001) over time and were higher 
(P < 0.05) in SD-33 pigs relative to VEH pigs (Figure 4A). Post-hoc analysis revealed that at 24 
h postchallenge, VEH+SALM pigs had fewer (P<0.05) circulating neutrophils than did SD-
33+SALM pigs. This pattern was also evident (but not statistically significant) at 48, 72, and 96 
h. Although treatment did not affect the percentage of WBC that were neutrophils (Figure 4B), 
percentages tended (P = 0.076) to change over time, suggesting that neutrophil percentages 
across treatments were elevated at 24 h relative to the pre-challenge state. 
Circulating lymphocyte concentrations increased (P < 0.0001) over time across treatment 
groups (Figure 5A).  An interaction was observed such that at 48 h postchallenge, VEH+SALM 
pigs had lower (P < 0.05) numbers of circulating lymphocytes than did VEH+CON pigs. At 72 
h, no effect of SALM was observed, but SD-33+CON pigs had greater numbers of circulating 
lymphocytes than did VEH+CON pigs. The percentage of WBC that were lymphocytes was not 
affected by treatment with SD-33 or SALM (Figure 5B). A trend was observed such that at 48 h 
postchallenge, SD-33+CON pigs had a lower (P = 0.087) percentage of WBC that were 
lymphocytes relative to VEH+CON pigs. 
Circulating monocytes increased (P < 0.0001) over time across all treatment groups, and 
in contrast to lymphocytes, were elevated following SD-33 (P < 0.001) and SALM (P < 0.05) 
treatments, although the effect of SALM tended (P = 0.082) to be influenced by time (Figure 
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6A). It should be noted that circulating monocyte concentrations differed between treatment 
groups prior to treatment (0 h). Treatment with SD-33 tended (P = 0.071) to increase the 
percentage of WBC that were monocytes. The percentage of monocytes in SALM treated pigs 
increased (P < 0.01) as well (Figure 6B). The percentage of WBC that was monocytes decreased 
(P < 0.005) at h 24 relative to pre-treatment levels. The percentage of circulating monocytes then 
gradually increased at 72 and 96 h to become greater (P = 0.005) than 0 h levels..  
Discussion 
Feed Intake 
As expected, FI was adversely affected by weaning in all treatment groups as seen 1 d 
post challenge (2 d postweaning). Pigs in all groups except SD-33+SALM recovered by d 2, and 
all groups were eating by d 3. At 2 d postchallenge, SD-33+CON pigs ate more than the other 
treatment groups, consistent with what we have observed previously in healthy pigs given SD-33 
immediately prior to weaning (Kojima et al., 2009; Chapter 2). Inoculation with Salmonella 
markedly reduced FI, particularly at 3 d postchallenge.  This reduction in FI is in agreement with 
previous studies which have shown decreased FI for up to 120 h postchallenge , depending 
somewhat on the dose given and the age of the pigs (Balaji et al., 2000; Jenkins et al., 2004). 
Simultaneous treatment with a single i.m. injection of 0.5 mole/kg SD-33 did not increase FI in 
immune-challenged pigs. Similarly, Obese et al. (2007) also found that SD-33 did not counteract 
the reduction in FI due to an LPS challenge in adult wethers. The effects of SD-33 may not be 
potent enough to overcome the decreased appetite seen in an immune challenge; timing of 
injection or strength of dose may need to be altered. 
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Body Weight 
Pigs challenged with Salmonella grew less over the 4 d trial period regardless of SD-33 
treatment. Even though the interaction between SD-33 and SALM did not reach significance, 
VEH+SALM pigs lost weight relative to pre-trial BW, whereas the SD-33+SALM pigs did not. 
In the previous studies (Kojima et al., 2009; Chapter 2) no effect on BW was observed in 
healthy, weaned pigs treated with SD-33, in spite of increased FI. As opioids exert their effects 
on many physiological processes, including appetite and immune function, SD-33 may be 
altering the partitioning of calories toward some other function than growth.  
Immune Cells 
The primary function of WBC is to prevent and fight infections. In the young pig, its 
success in dealing with a pathogen may be dependent on the degree to which stress is affecting 
immune function. In the current study, the pigs were relatively stressed due to weaning and 
cannulation the day before. Neutrophil, lymphocyte, and monocyte numbers increased over time 
across all treatment groups. We have previously reported increases in total WBC count, 
neutrophils, lymphocytes and monocytes over time in newly-weaned pigs (Kojima et al., 2009; 
Chapter 2). Circulating immune cell population’s increase at 1 d postweaning and return to pre-
weaning levels by 7 d postweaning (Kojima et al., 2008, Cooper et al., 2009). It would appear 
that immune cell populations continue to increase for several days postweaning. This may 
indicate prolonged inhibition of chemotaxis by cortisol and a progressive accumulation of cell 
numbers.  
Treatment with SD-33 increased circulating monocyte concentrations, most noticeably at 
2 d postchallenge. We have previously shown that SD-33 tended to selectively increase the 
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number of circulating monocytes in healthy pigs given SD-33 immediately prior to weaning 
(Kojima et al., 2009; Chapter 2), although the response did not reach statistical significance.  
Opioids are known to have immuno-modulary functions, and cells of the immune system 
(neutrophils, monocytes, and lymphocytes) express opioid receptors, as reviewed by Finley et al. 
(2008). Grimm et al. (1998) reported that endogenous met-enkephalin and morphine induced 
monocyte chemotaxis, but inhibited chemokine-induced chemotaxis of human neutrophils; these 
responses were blocked by naloxone. Recent evidence (Finley et al., 2008) suggests that 
activation of κ-opioid receptors may induce an anti-inflammatory response while activation of µ-
opioid receptors induces a pro-inflammatory response. Naloxone, although primarily known as a 
µ-opioid receptor agonist, also is an antagonist to κ- and δ-opioid receptors. While most of the 
published data suggests that SD-33 is a µ-opioid, the possibility that this molecule may also bind 
one of the other opioid receptor subtypes must be considered. 
An oral challenge of Salmonella would typically recruit circulating WBC to the gut, 
thereby decreasing circulating concentrations of neutrophils and lymphocytes. While this 
decrease in circulating cell numbers was observed at 48 h post challenge in VEH+SALM pigs, 
co-treatment with SD-33 appears to have blocked this effect. The exact mechanism for this is as 
yet undetermined, but may involve the inhibition of chemotaxis of neutrophils (and other WBC 
cell types) as described above. 
In an intriguing examination of the effects of opioids, Stefano and Kream (2008) stated 
that opioids originated as immune signaling molecules for microbial invasions. Proenkephalins 
contain an antibacterial peptide called enkelytin (Goumon et al., 1996) that is co-secreted with 
  
53 
 
 
other immune signaling molecules to instantly attack pathogens while allowing time for immune 
recruitment (Stefano et al., 1998).  
Implications 
 
We have demonstrated that although co-treatment with SD-33 during an immune 
challenge did not result in increased feed intake, SD-33 exerted effects relating to circulating 
populations of immune cells. Further work is needed to determine if these effects are beneficial 
or harmful to the immune-challenged newly-weaned pig. 
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A) 
 
 
B) 
 
 
Figure 1: A) Daily and B) cumulative feed intake of pigs injected with SD-33 (0.05 μmole/kg 
syndyphalin-33) or saline, concurrent with an oral gavage of Salmonella enterica (5 x 10
9
 CFU) 
or sterile broth. For both graphs, raw means and standard errors are shown. 
a-d 
Means of time 
points (across treatments) with unidentical letters differ (P < 0.05).  
0
.05
.1
.15
.2
.25
.3
.35
.4
D
ai
ly
 F
ee
d 
In
ta
ke
, k
g
1                             2                           3    4     
Days post-injection
PSD = n.s.
PSALM < 0.05
PTIME < 0.0001
PSALM*TIME < 0.05
PSD*SALM*TIME < 0.05
d 
c 
b 
a 
SD-33/Salmonella -/- -/+             +/- +/+ 
Key          
D
ai
ly
 F
ee
d 
In
ta
ke
, k
g
0
.2
.4
.6
.8
1
1.2
C
um
ul
at
iv
e f
ee
d 
in
ta
ke
, k
g
PSD = n.s.
PSALM < 0.05
PSD*SALM = 0.065
-/- -/+                    +/- +/+   
SD-33/Salmonella
Cumulative Feed Intake
C
um
ul
at
iv
e f
ee
d 
in
ta
ke
, k
g
C
um
ul
at
iv
e f
ee
d 
in
ta
ke
, k
g
C
um
ul
at
iv
e f
ee
d 
in
ta
ke
, k
g
  
60 
 
 
 
 
Figure 2: Cumulative weight gain of pigs injected with SD-33 (0.05 μmole/kg syndyphalin-33) 
or saline, concurrent with an oral gavage of Salmonella enterica (5 x 10
9
 CFU) or sterile broth. 
Raw means and standard errors are shown. 
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Figure 3: Total white blood cell count of pigs injected with SD-33 (0.05 μmole/kg syndyphalin-
33) or saline, concurrent with an oral gavage of Salmonella enterica (5 x 10
9
 CFU) or sterile 
broth. Raw means and standard errors are shown. 
a-c 
Above brackets, means of time points 
(across treatments) with unidentical letters differ (P < 0.05). 
a-b 
Below brackets, means of 
treatments (within a time) with unidentical letters differ (P < 0.05). 
0
2
4
6
8
10
12
14
16
18
W
h
it
e 
b
lo
o
d
 c
el
ls
, 
1
0
0
0
 p
er
 µ
L
0                      24                   48                  72                    96        
Hours post-injection
PSD < 0.0001
PSALM = n.s.
PTIME < 0.0001
PSD*SAL < 0.05
c
c
b
b
a
n.s.
n.s.
a   b   a   a 
b   b   a  ab 
ab  b   a   a 
SD-33/Salmonella -/- -/+             +/- +/+ 
Key          
Absolute White Blood Cell Concentration
W
h
it
e 
b
lo
o
d
 c
el
ls
, 
1
0
0
0
 p
er
 µ
L
W
h
it
e 
b
lo
o
d
 c
el
ls
, 
1
0
0
0
 p
er
 µ
L
W
h
it
e 
b
lo
o
d
 c
el
ls
, 
1
0
0
0
 p
er
 µ
L
W
h
it
e 
b
lo
o
d
 c
el
ls
, 
1
0
0
0
 p
er
 µ
L
W
h
it
e 
b
lo
o
d
 c
el
ls
, 
1
0
0
0
 p
er
 µ
L
  
62 
 
 A) 
 
 
 
B) 
 
Figure 4: A) Absolute and B) percent neutrophils counts of pigs injected with SD-33 (0.05 
μmole/kg syndyphalin-33) or saline, concurrent with an oral gavage of Salmonella enterica (5 x 
10
9
 CFU) or sterile broth. For both graphs, raw means and standard errors are shown. 
a-b 
Above 
brackets, means of time points (across treatments) with unidentical letters differ (P < 0.05). 
a-b 
Below brackets, means of treatments (within a time) with unidentical letters differ (P < 0.05).   
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 A) 
  
B) 
 
Figure 5: A) Absolute and B) percent lymphocytes of pigs injected with treatment allocations 
(SD-33 = 0.05 μmole/kg syndyphalin-33; SALM = 3 mL of 5x109 CFU of live Salmonella 
enterica) over 4 days post-treatment. For both graphs, raw means and standard errors are shown.  
a-c 
Above brackets, means of time points (across treatments) with identical letters differ (P < 
0.05). 
a-b 
Below brackets, means of treatments (within a time) with unidentical letters differ (P < 
0.05). 
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 A) 
 
B) 
Figure 6: A) Absolute and B) percent monocyte counts of pigs injected with injected with 
treatment allocations (SD-33 = 0.05 μmole/kg syndyphalin-33; SALM = 3 mL of 5x109 CFU of 
live Salmonella enterica). For both graphs, raw means and standard errors are shown. 
a-c 
Above 
brackets, means of time points (across treatments) with unidentical letters differ (P < 0.05). 
a-b 
Below brackets, means of treatments (within a time) with unidentical letters differ (P < 0.05). 
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CHAPTER FOUR 
Conclusions and Implications 
 
The results of this research has demonstrated that the synthetic enkephalin Syndyphalin-33 
(SD-33) has potential to be used as an agent to increase feed intake and decrease the negative 
effects of stress during weaning in pigs.  It has also demonstrated that, although co-treatment 
with SD-33 during an immune challenge did not result in increased feed intake, SD-33 exerted 
effects relating to circulating populations of immune cells, suggesting that this opioid may act as 
an anti-inflammatory in recently weaned pigs. Work is underway to confirm the anti-
inflammatory effect. Further investigation is needed to better understand the timing of effect, and 
to rule out any immunosuppressive effects, which would be detrimental to the animal’s well- 
being. 
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